We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
MD Anderson Receives $22.2M in CPRIT Research Funding
News

MD Anderson Receives $22.2M in CPRIT Research Funding

MD Anderson Receives $22.2M in CPRIT Research Funding
News

MD Anderson Receives $22.2M in CPRIT Research Funding

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "MD Anderson Receives $22.2M in CPRIT Research Funding"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Thirty-six percent of funds awarded for Individual Investigator Awards (IIA) went to MD Anderson faculty as well as nearly 40 percent of funds awarded for recruitment, reflecting the excellence and impact of the institution’s world-class cancer researchers and star recruitment candidates.

Across Texas institutions, CPRIT awarded a total of $112 million in 73 new grants. MD Anderson CPRIT awards included $14.8 million for research, $6 million in recruitment funding and $1.4 million for evidence-based cancer prevention services. Consistent with MD Anderson’s broad research program, these CPRIT awards will fund exciting studies in cancers of the liver, skin, pancreas, and ovary, as well as lymphoma, leukemia and other cancers. A full listing of individual awards can be found below.

“We are extremely grateful to the citizens of Texas for supporting truly important and life-saving cancer research. CPRIT is helping our gifted faculty in Making Cancer History,” said MD Anderson President Ronald DePinho, M.D. “This vital funding also has proved to be a powerful force in attracting the nation’s best research talent to our institution. I applaud our investigators who were awarded funding, as well as all the scientists, clinicians and citizens who share our goal of ending cancer.”

Advertisement